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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A275(r¼.20). Baseline KOOS4 scores were also related to all 5 year KOOS
subscores (all outcomes p<0.01, r¼.23 to r¼.29) (Table 1).
Conclusions: Cartilage injury at baseline was related to worse patient
reported 5 year outcome. Baseline subchondral fracture and meniscus
injury were not related to 5 year outcome, however, receiving medial
meniscus surgerywas related toworse pain,QOL andkneeconﬁdence at 5
year follow-up. In comparison, lateralmeniscus surgerywasnot related to
5 year outcome. Undergoing ACLR (early or delayed) was associated with
more knee symptoms at 5 years and treatment with rehabilitation alone
resulted in worse knee conﬁdence. More joint pain, symptoms, poorer
physical function and worse QOL in the acute phase of ACL injury, were
related to worse 5 year outcome, irrespective of intervention.
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MICRORNA-33A REGULATES CHOLESTEROL SYNTHESIS AND
CHOLESTEROL EFFLUX RELATED GENES IN OSTEOARTHRITIC
CHONDROCYTES
F. Kostopoulou y, K.N. Malizos z, I. Papathanasiou y, A. Tsezou y. yDept. of
Cytogenetics and Molecular Genetics, Univ. of Thessaly, Larissa, Greece;
zDept. of Orthopaedics, Univ. of Thessaly, Larissa, Greece
Purpose: Several studies have shown that osteoarthritis (OA) is strongly
associated to metabolic related disorders, highlighting OA as the ﬁfth
component of the Metabolic Syndrome (MetS). Based on our previous
ﬁndings on dysregulation of cholesterol homeostasis in OA, we were
prompted to investigate whether microRNA-33a (miR-33a), one of the
master regulators of cholesterol and fatty acid metabolism, plays a key
role in osteoarthritis' pathogenesis.
Methods: Articular cartilage samples were obtained from 14 patients
with primary osteoarthritis undergoing total knee replacement surgery.
Normal cartilage was obtained from 9 individuals undergoing fracture
repair surgery with no history of joint disease. Bioinformatics was used
to identify miR-33a target genes. MiR-33a and Sterol Regulatory Ele-
ment Binding Protein 2 (SREBP-2) expression levels were investigated
using real-time PCR and their expression was also assessed after
treatment with Transforming Growth Factor-beta (TGF-beta) in cul-
tured chondrocytes. Investigation of Akt phosphorylation after treat-
ment with both TGF-beta and miR-33a inhibitor was assessed by
western blot analysis. Furthermore, we evaluated the effect of miR-33amimic and miR-33a inhibitor on cholesterol efﬂux related genes, ATP-
binding-cassette transporter A1 (ABCA1), Apolipoprotein A1 (ApoA1),
liver X receptors (LXRalpha and LXRbeta), as well as on matrix metal-
loproteinase-13 (MMP-13) using real time PCR assay.
Results: We found that the expression of miR-33a and its host gene
SREBP-2 were signiﬁcantly elevated in OA chondrocytes compared to
normal. We also showed that treatment of cultured chondrocytes with
TGF-beta resulted in increased expression of both miR-33a and SREBP-
2, while the TGF-beta-induced Akt phosphorylation was suppressed by
inhibition of miR-33a. Moreover, we demonstrated that treatment of
normal chondrocytes with miR-33a resulted in ABCA1 and ApoA1 sig-
niﬁcantly reduced mRNA expression levels and signiﬁcantly elevated
MMP-13 expression levels, promoting the OA phenotype, while miR-
33a's suppressive effect was reversed using its inhibitor.
Conclusions: Our ﬁndings suggest, for the ﬁrst time to our knowledge,
that miR-33a regulates cholesterol synthesis through the TGF-beta/Akt/
SREBP-2 pathway, and cholesterol efﬂux related genes ABCA1 and
ApoA1 in OA chondrocytes, pointing to its identiﬁcation as a novel
target for ameliorating the OA phenotype.
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Purpose: The purpose of this study was to determine the role of
microRNA-140 in an in vitro model of osteoarthritis (OA).
Methods: Human articular chondrocytes (ACs) and synovial ﬁbroblasts
(SFs) were isolated from patients undergoing total knee replacement
and anterior cruciate ligament surgery, respectively. Addition of
recombinant IL1B to cell cultures was used as an in vitro model of OA.
All patients provided written, informed consent. Electroporation was
used to overexpress microRNA-140. Real-time PCR was used to quantify
mRNA levels and genome-scale proteome quantiﬁcationwas performed
using mass spectrometry. ELISA and western blotting were used to
validate results from the proteome analysis.
Results: IL1B-stimulation of ACs resulted in upregulation and down-
regulation of 200 and 160 proteins, respectively. The upregulated pro-
teins included several pro-inﬂammatorymolecules such as IL1B, IL6, IL8
and the matrix degradation molecules MMP3 and MMP13. All these
proteins are known to be involved in the pathogenesis of OA.
When microRNA-140 was overexpressed in IL1B-stimulated ACs 100
and 90 proteins were downregulated and upregulated, respectively. The
downregulated proteins included IL1B, IL6, IL8, proteins involved in NF-
kappaB signaling and other proteins that are associated with OA.
However, MMP3 and MMP13 were not affected. ACAN, CSGALNACT1
(involved in chondroitin sulfate biosynthesis), proteins involved in
hyaluronan synthesis/binding and inhibitors of NF-kappaB signaling
were among the proteins that were upregulated by miR-140. The
remaining proteins were mainly associated with cell cycle and
metabolism.
Conclusions: Addition of low levels of IL1B to cultures of ACs or SFs
constitute useful in vitro models for the pathogenesis of OA. In this
study we show that microRNA-140 protects against OA by inhibiting
key inﬂammatory molecules and stimulating synthesis of important
cartilage molecules. Delivery of microRNA-140 into OA joints may
represent a viable treatment strategy.
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MICRORNA-455 TARGETS SIRT1
T.E. Swingler y, Y. Wormstone y, M. Lott y, M. Barter z, D. Young z,
I.M. Clark y. yUniv. of East Anglia, Norwich, United Kingdom; zUniv. of
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Purpose: MicroRNAs (miRNAs) have emerged as a new class of gene
expression regulators that are important in both normal cartilage
physiology and pathology. MicroRNAs are 20-24 nucleotide non-
coding RNA molecules that post-transcriptionally regulate gene
expression. A single miRNA can regulate multiple mRNAs via binding
to sequences in the 30UTR either promoting mRNA decay or repres-
sing translation. We have previously identiﬁed several microRNAs
that are regulated during chondrogenesis and in osteoarthritic car-
tilage, including microRNA-455, a key Sox9-responsive microRNA.
